1. "High" antiretroviral deintensification, a strategy to avoid drug interactions and unfavourable long-term effects of HAART. Issue 10 (3rd October 2018) Authors: Lanzafame, Massimiliano; Piacentini, Daniela; Lattuada, Emanuela; Rizzardo, Sebastiano; Chiesi, Sheila; Vento, Sandro Journal: Infectious diseases Issue: Volume 50:Issue 10(2018) Page Start: 788 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Acute liver failure. Issue 10240 (13th June 2020) Authors: Vento, Sandro; Cainelli, Francesca Journal: Lancet Issue: Volume 395:Issue 10240(2020) Page Start: 1833 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. An Investigation of Liquid Chromatography–Mass Spectral Attributes and Analytical Performance Characteristics of Tenofovir, Emtricitabine and Efavirenz in Human Plasma. (20th October 2015) Authors: Ndolo, Sedireng M.; Sichilongo, Kwenga; Massele, Amos; Sepako, Enoch; Vento, Sandro Journal: Journal of analytical toxicology Issue: Volume 40:Number 1(2016) Page Start: 49 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Cerebral palsy: a multidisciplinary, integrated approach is essential. Issue 4 (April 2017) Authors: Bulekbayeva, Sholpan; Daribayev, Zholtay; Ospanova, Sholpan; Vento, Sandro Journal: Lancet Issue: Volume 5:Issue 4(2017) Page Start: e401 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Chronic liver diseases must be reduced worldwide: it is time to act. Issue 4 (April 2022) Authors: Vento, Sandro; Cainelli, Francesca Journal: Lancet Issue: Volume 10:Issue 4(2022) Page Start: e471 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Clinical course of infection with hepatitis C. Issue 7538 (16th February 2006) Authors: Vento, Sandro; Nobili, Valerio; Cainelli, Francesca Journal: BMJ Issue: Volume 332:Issue 7538(2006) Page Start: 374 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Dolutegravir 50 mg thrice weekly plus atazanavir 400 mg daily in a long-term virologically suppressed HIV-infected patient. (June 2017) Authors: Lanzafame, Massimiliano; Lattuada, Emanuela; Nicolè, Stefano; Rigo, Fabio; Cucchetto, Giulia; Concia, Ercole; Vento, Sandro Journal: International journal of STD & AIDS Issue: Volume 28:Number 7(2017:Jul.) Page Start: 726 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Dolutegravir monotherapy and body weight gain in antiretroviral naïve patients. (1st August 2019) Authors: Rizzardo, Sebastiano; Lanzafame, Massimiliano; Lattuada, Emanuela; Luise, Dora; Vincenzi, Marcello; Tacconelli, Evelina; Vento, Sandro Journal: AIDS Issue: Volume 33:Number 10(2019) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Dolutegravir monotherapy in HIV-1-suppressed patients: A feasible regimen in real life. (February 2018) Authors: Lattuada, Emanuela; Lanzafame, Massimiliano; Nicolè, Stefano; Rigo, Fabio; Cucchetto, Giulia; Concia, Ercole; Vento, Sandro Journal: International journal of STD & AIDS Issue: Volume 29:Number 2(2018) Page Start: 206 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Dolutegravir Monotherapy in HIV-Infected Naive Patients With <100, 000 Copies/mL HIV RNA Load. (1st May 2016) Authors: Lanzafame, Massimiliano; Gibellini, Davide; Lattuada, Emanuela; Signoretto, Caterina; Mazzi, Romualdo; Concia, Ercole; Vento, Sandro Journal: Journal of acquired immune deficiency syndromes Issue: Volume 72:Number 1(2016) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗